Borealis Ventures — 2020 Investments

1 investments dated 2020 · listed companies and verified rows first · show all

Compass Therapeuticscompasstherapeutics.com in 𝕏NASDAQ: CMPXJun 2020 · $60M

Compass Therapeutics uses proprietary antibody discovery platforms to generate and screen diverse panels of monoclonal and multispecific antibodies, aiming to identify synergistic therapeutic combinations.

BiotechHealthtechCambridge, US

Schuetz Thomas(Executive Officer, Director)in Errik Anderson(Executive Officer, Director)in Thomas J. Schuetz(Executive Officer, Director)inVered Bisker-Leib(Executive Officer)inBarry Shin(Chief Financial Officer)in Neil Lerner(Senior Vice President, Chief Accounting Officer)in

Co-investorsBioBrit F-Prime Capital Foresite Capital OrbiMed venBio Partners Vivo Capital +1 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.